PC
ASBPW

Periscope Capital’s Aspire Biopharma Warrant ASBPW Stock Holding History

Periscope Capital’s Portfolio ASBPW Stock Details ASBPW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.07K Hold
124,924
– – ﹤0.01% 422
2025
Q4 		$2.06K Hold
124,924
– – ﹤0.01% 343
2025
Q3 		$3.73K Hold
124,924
– – ﹤0.01% 282
2025
Q2 		$5.59K Sell
124,924
-283,643
-69% -$14K ﹤0.01% 226
2025
Q1 		$29.8K Sell
408,567
-145,633
-26% -$8.77K 0.01% 138
2024
Q4 		$26.3K Sell
554,200
-2,100
-0.4% -$57 0.01% 120
2024
Q3 		$23.5K Sell
556,300
-262,300
-32% -$12.5K 0.01% 131
2024
Q2 		$30.6K Sell
818,600
-643,365
-44% -$23.6K 0.01% 169
2024
Q1 		$44K Hold
1,461,965
– – 0.01% 229
2023
Q4 		$87.7K Hold
1,461,965
– – 0.01% 212
2023
Q3 		$74.1K Hold
1,461,965
– – 0.01% 333
2023
Q2 		$73.2K Buy
1,461,965
+25,000
+2% +$918 0.01% 390
2023
Q1 		$60.1K Buy
1,436,965
+8,500
+0.6% +$562 ﹤0.01% 510
2022
Q4 		$87.9K Buy
1,428,465
+489,865
+52% +$32.9K ﹤0.01% 514
2022
Q3 		$120K Buy
938,600
+570,000
+155% +$83K ﹤0.01% 610
2022
Q2 		$63K Buy
+368,600
New +$80.2K ﹤0.01% 663

Other funds holding ASBPW

MTCM
Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 18.84% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 12.96% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.91% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.5% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Periscope Capital's ASBPW Position: Q1 2026 in Review

Periscope Capital held its Aspire Biopharma Warrant (ASBPW) position steady in Q1 2026 at 124,924 shares worth $2.07K. The position accounts for ﹤0.01% of the portfolio, ranked #422.

Periscope Capital first reported a position in ASBPW in Q2 2022 and has held it in 16 quarters since. The position peaked at $120K in Q3 2022. 29 funds tracked by Wall St. Rank hold ASBPW as of Q1 2026.

  • Periscope Capital held 124,924 shares of Aspire Biopharma Warrant worth $2.07K as of Q1 2026.
  • Periscope Capital left its Aspire Biopharma Warrant share count unchanged in Q1 2026.
  • Aspire Biopharma Warrant made up ﹤0.01% of Periscope Capital's portfolio in Q1 2026, its #422 holding.
  • Periscope Capital first reported a position in Aspire Biopharma Warrant in Q2 2022 and has held it in 16 quarters since.
  • Periscope Capital's Aspire Biopharma Warrant position peaked at $120K in Q3 2022.
  • 29 funds tracked by Wall St. Rank held Aspire Biopharma Warrant as of Q1 2026.

Based on Periscope Capital's 13F filing for Q1 2026, filed 14 May 2026.